Lobbying client · LD-2 disclosures
Ziopharm Oncology, Inc.
Massachusetts
9 filings from 2 registrants · 2008–2013 · latest filed Jul 24, 2013
Reported on its behalf
$340K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$340K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medical/Disease Research/Clinical Labs
MED
7 filings
$290K on those filings
Health Issues
HCR
3 filings
$90K on those filings
Pharmacy
Who did the lobbying
Every lobbyist named on this client's filings.
- WENDY SHELTON dvm Fabiani & CompanyCovered position: Legislative Fellow; Office of Sen. Lieberman4 filingsthrough 2010
- Melissa Dupree The Conafay Group, LLC2 filingsthrough 2013
- Ravi Sawhney Fabiani & Company2 filingsthrough 2012
- James P Fabiani Fabiani & Company2 filingsthrough 2008
- Stephen R Conafay Fabiani & Company1 filing
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: ziopharm-oncology-inc.